BioCentury | Feb 23, 2015
Emerging Company Profile
Eyeing new antibiotics
...by inhibiting protein, DNA, or cell wall synthesis but require multiplying cells to be effective. SinSa Laboratories...
...NASDAQ:DPRX), New York, N.Y. Lytix Biopharma A/S , Tromso, Norway Singapore Eye Research Institute, Singapore SinSa Laboratories Inc....
...highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections." Journal of Medicinal Chemistry (2015) Sidebars SinSa Laboratories Inc....
...NASDAQ:DPRX), New York, N.Y. Lytix Biopharma A/S , Tromso, Norway Singapore Eye Research Institute, Singapore SinSa Laboratories Inc....
...highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections." Journal of Medicinal Chemistry (2015) Sidebars SinSa Laboratories Inc....
